The peripheral blood CD4+ T cells from children with new onset T1DM secrete higher levels of IL-17 and IL-22 than those from healthy individuals upon polyclonal activation, and there was no increase in IFN-γ levels or T-bet expression in patients with T1DM [69]. This evidence concerns the gene IL22 and type 1 diabetes mellitus.